> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Extended on Abuse-deterrent Properties for Opioids
- URL: https://www.fdaweb.com/comments-extended-on-abuse-deterrent-properties-for-opioids/
- Published: 2016-12-05T12:00:00.000Z
- Updated: 2026-09-14T21:52:36.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137492

*Federal Registe*r Notice: FDA has extended the comment period related to its public meeting on “Pre-Market Evaluation of Abuse-Deterrent Properties of Opioid Drug Products.” Comments are sought on the approach to testing that FDA recommended in its draft guidance on “General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products,” and on FDA’s efforts to develop standardized *in vitro* testing methodologies for evaluating the abuse deterrence of opioid drug products. Written comments are being accepted until 1/3/2017\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-12-05/pdf/2016-29097.pdf?ref=fdaweb.com).